Bone Grafts and Substitutes Market Set to Surge to $4.4 Billion by 2033 at a 4.4% CAGR

January 30, 2025 04:23 PM AEDT | By EIN Presswire
 Bone Grafts and Substitutes Market Set to Surge to $4.4 Billion by 2033 at a 4.4% CAGR
Image source: EIN Presswire
PORTLAND, IL, UNITED STATES, January 30, 2025 /EINPresswire.com/ -- Increase in the number of spinal & joint construction surgeries, trauma cases and innovation in the orthopedic sectors is expected to drive the growth of the bone grafts and substitutes market.

The bone grafts and substitutes market was valued at $2,586.30 million in 2021, and is projected to reach $4,005.26 million by 2031, registering a CAGR of 4.5% from 2022 to 2031.

Request Sample of the Report on - https://www.alliedmarketresearch.com/request-sample/1774

Bone substitutes are synthetic materials that are designed to mimic the structure and function of natural bone. They are made from a variety of materials such as ceramics, metals, and polymers. These substitutes can be used alone or in combination with bone grafts to help promote bone growth and healing. They are used in a similar range of conditions as bone grafts such as spinal fusion, fracture repair and bone cancer treatment.

The global bone grafts and substitutes market is grouped into various segments based on type, application, end user, and region. It is offered in both graphical and tabular form, authorizing an individual or a commercial enterprise to benefit perception into the highly profitable and rapidly growing segments.

Key Takeaways:

The bone grafts substitute segment would dominate the market in terms of revenue through 2031.

The spinal fusion segment held the major share in 2021, garnering nearly half of the global bone grafts and substitutes market revenue and is projected to maintain the lion’s share through 2031.

The hospitals segment is expected to maintain its lead in terms of revenue during the forecast period.

Asia-Pacific market is expected to manifest the fastest CAGR of 5.3% during the forecast period.

In terms of type, the bone grafts substitute segment dominates the highest market share in 2021, holding more than half of the global bone grafts and substitutes market revenue, and is expected to lead the trail by 2031. The cell-based matrices segment, on the other hand, would display the fastest CAGR of 5.1% from 2022 to 2031. The allografts segment is also discussed in the report.

Want to Explore More, Connect to our Analyst - https://www.alliedmarketresearch.com/connect-to-analyst/1774

Moreover, the bone grafts and substitutes market trends are the ongoing technological advancements in the field of orthopedic surgery, resulting in the development of new and improved products that are effective and easier to use. These innovations are expected to increase demand for bone grafts and substitutes, and drive the bone grafts and substitutes market forecast.

However, factors such as high cost and regulatory concerns are projected to limit the growth of the bone grafts and substitutes market. The cost of bone grafts and substitutes can be relatively high, which is anticipated to limit the adoption of these products by some patients. In addition, approval process for new bone graft and substitute products can be lengthy and costly, which could limit the development and introduction of new products to the market. Thus, high cost and regulatory approvals restrain the growth of the bone grafts and substitutes market.

Moreover, increase in incidence of sport injuries, expansion of application of bone grafts & substitutes in spinal fusion, trauma surgery and surge in awareness about the same are the factors which provide lucrative opportunities to the key players of the market.

Market Segmentation:

By Type:

Allografts-

Machined allografts
Demineralized bone matrix

Bone grafts substitutes-

Bone morphogenic proteins (BMP)
Synthetic bone grafts

Cell based matrices-

By Application:

Spinal fusion
Trauma
Joint reconstruction
Dental bone grafting
Craniomaxillofacial

By End User:

Hospitals
Specialty clinics
Others

By Region:

North America (U.S., Canada, Mexico)
Europe (France, Germany, Italy, Spain, UK, Rest of Europe)
Asia-Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
LAMEA (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)

For Procurement Information - https://www.alliedmarketresearch.com/purchase-enquiry/1774

The report also provides an in-depth analysis of the top players in the global bone grafts and substitutes market, they are as mentioned: Xtant Medical Holdings, Inc., Stryker Corporation, Johnson & Johnson, Integra LifeSciences, Baxter International Inc., Medtronic plc, Nuvasive, Inc., Arthrex, Inc., Zimmer Biomet Holdings, Inc., and Orthofix Holdings, Inc. these leading players have adopted various strategies such as partnerships, agreements, mergers & acquisitions, new technological advances, and new product launches to maintain their foothold in the market.

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Market Research
+ 1 800-792-5285
email us here
Visit us on social media:
Facebook
X
LinkedIn
YouTube

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.